BackHeat Biologics Overview

Heat Biologics Current Assets

Latest current assets for HTBX: $2.1T.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$2121.63B

Peer trimmed avg / median

Loading

Heat Biologics Current Assets History

Loading

Heat Biologics vs. peers: Current Assets Comparison

Loading

Heat Biologics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Heat Biologics (HTBX) FAQ

As of the most recent data (September 2025), HTBX shows a current assets of $2.1T. Scroll down for historical charts and peer comparison views.

Tracking HTBX's current assets over time shows whether Heat Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $2.1T Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Heat Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $2.1T) with ownership activity and broader fundamentals.

Heat Biologics's current assets is $2.1T; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.